Diplomat Pharmacy (DPLO) Form 4 Diplomat Pharmacy / Philip R Hagerman ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hagerman Philip R

(Last) (First) (Middle)

4100 S. SAGINAW STREET

(Street)

FLINT MI 48507

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Diplomat Pharmacy, Inc. [ DPLO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2018		A		5,222(1)	A	$0	5,222	D
Common Stock								1,330,099	I	Philip R. Hagerman Revocable Trust(2)
Common Stock								3,391,609	I	2007 Hagerman Family GST(3)
Common Stock								3,600,091	I	The JH GST Trust(2)
Common Stock								1,475,876	I	2013 Irrev. Exempt Trust for Daughter(3)
Common Stock								1,475,876	I	2013 Irrev. Exempt Trust for Son(3)
Common Stock								1,075,293	I	2013 Irrev. Exempt Trust for Daughter(2)
Common Stock								1,311,292	I	2013 Irrev. Exempt Trust for Daughter(2)
Common Stock								313,337	I	2014 Irrev. Exempt Trust for Son(3)
Common Stock								313,337	I	2014 Irrev. Exempt Trust for Daughter(3)
Common Stock								313,337	I	2014 Irrev. Exempt Trust for Daughter(2)
Common Stock								313,337	I	2014 Irrev. Exempt Trust for Daughter(2)
Common Stock								417,528	I	Jocelyn Hagerman Living Trust(3)
Common Stock								263,500	I	JH Marital Trust(2)
Common Stock								272,000	I	PH Marital Trust(3)
Common Stock								394,910	I	Irrevocable Trust for Son
Common Stock								394,910	I	Irrevocable Trust for Daughter
Common Stock								367,256	I	Irrevocable Non-Exempt Trust for Son
Common Stock								367,256	I	Irrevocable Non-Exempt Trust for Daughter

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of restricted stock were granted in connection with the Issuer's revised non-employee director compensation program, effective October 1, 2018.

2. These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.

3. Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her as a trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, the Jocelyn Hagerman Living Trust, and the PH Marital Trust.

	/s/ Christina Flint, by Power of Attorney	10/03/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.